Trial intelligence / Profile preview

SERPA: Safety and efficacy of D-allulose in males with autism spectrum disorder

jRCTs031180411Completed

Sponsor
Ministry of Education, Culture, Sports, Science and Technology
Start
Mar 2019
Countries
1
01

Overview

Randomised, double-blind trial in Autism Spectrum Disorder (ASD) and obesity (2 arms), sponsored by Ministry of Education, Culture, Sports, Science and Technology. Primary endpoint: Safety and tolerability (adverse events). Started Mar 2019; status: completed.

02

Conditions

Autism Spectrum Disorder (ASD)obesity

Beyond the preview

Go deeper on jRCTs031180411.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs031180411.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call